Escalon Medical Corp.
ESMC · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $12 | $12 | $12 | $11 |
| % Growth | 0.5% | -1.6% | 13.8% | – |
| Cost of Goods Sold | $7 | $7 | $7 | $6 |
| Gross Profit | $6 | $5 | $5 | $5 |
| % Margin | 45.7% | 43% | 45% | 43% |
| R&D Expenses | $753 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4,625 | $5 | $4 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$5,372 | $0 | $0 | $0 |
| Operating Expenses | $5 | $5 | $5 | $5 |
| Operating Income | $0 | -$0 | $0 | $0 |
| % Margin | 1.1% | -0.9% | 3.9% | 0.3% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | $0 | -$0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | -$0 | $0 | $0 |
| % Margin | 0.9% | -1% | 3.8% | 0.2% |
| EPS | 0.004 | -0.024 | 0.062 | 0.002 |
| % Growth | 115.9% | -138.8% | 2,466.7% | – |
| EPS Diluted | 0.002 | -0.024 | 0.034 | 0.002 |
| Weighted Avg Shares Out | 7 | 7 | 7 | 7 |
| Weighted Avg Shares Out Dil | 14 | 7 | 14 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $23 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$0 | $1 | $0 |
| % Margin | 1.4% | -0.5% | 4.3% | 3.4% |